Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients
Clinical trial NCT02531412 · UNKNOWN
Trial details
- NCT number
- NCT02531412
- Sponsor
- Instituto Nacional de Cancerologia de Mexico
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-08-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.